close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
99 100 Next >
News headline image
Invivyd and the SPEAR Study Group Announce Initiation of “FLINTLOCK” Phase 2 Study of VYD2311, a Monoclonal Antibody for the Potential Treatment of Long COVID or Post-Vaccination Syndrome
From Invivyd, Inc.
Via GlobeNewswire
Tickers IVVD
News headline image
Seyond to Showcase Live LiDAR Operational Twin Demo at Dell Technologies and NVIDIA Booth at Smart City Expo World Congress 2026
From Seyond Inc
Via GlobeNewswire
News headline image
Alpha Compute Signs Binding GPU Contract, Leasing ALPHA-03 cluster under Four-Year, $81.7 Million Agreement in its Missouri Superintelligence Factory
From Alpha Compute Corp.
Via GlobeNewswire
Tickers ALP
News headline image
PyroGenesis Receives $860,000 Down Payment for Recently Announced Two-Torch Contract with European Mining, Metallurgy & Materials Client
From PyroGenesis Inc.
Via GlobeNewswire
Tickers PYRGF TSX:PYR
News headline image
Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Top Dose of 18 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study
From Entrada Therapeutics, Inc.
Via GlobeNewswire
Tickers TRDA
News headline image
Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis
From Parabilis Medicines, Inc.
Via GlobeNewswire
Tickers PBLS
News headline image
Matchpoint Therapeutics Expands Leadership Team with Appointment of John O’Malley, M.D., Ph.D., as Chief Medical Officer
From Matchpoint Therapeutics
Via GlobeNewswire
News headline image
Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (DMD) in the Phase 1/2 ELEVATE-45-201 Study of ENTR-601-45
From Entrada Therapeutics, Inc.
Via GlobeNewswire
Tickers TRDA
News headline image
Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026
From Axogen, Inc.
Via GlobeNewswire
Tickers AXGN
News headline image
Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and Advances Huntington's Disease Franchise
From Arexera Therapeutics
Via GlobeNewswire
News headline image
Elion Therapeutics Expands Pipeline with Exclusive Global License to Inhaled Antifungal for Immunocompromised Patients
From Elion Therapeutics
Via GlobeNewswire
News headline image
Orvida Pharma Announces FDA Acceptance of KM-023 (ontivatrep) into Rare Disease Evidence Principles Process for Olmsted Syndrome
From Orvida Pharma Ltd
Via GlobeNewswire
News headline image
Guns.com Dealer Network Sales Surge Nationwide Heading into the Holiday Season
From Guns.com
Via GlobeNewswire
News headline image
Macerich Schedules Third Quarter 2026 Earnings Release and Conference Call
From Macerich Company
Via GlobeNewswire
Tickers MAC
News headline image
Peoples, Ltd. Begins Trading on OTCQX Best Market
From OTC Markets
Via GlobeNewswire
Tickers OTCM PPLL
News headline image
Climb adds Netwrix to its Security Portfolio, Bringing Data and Identity Security to VARs and MSPs
From Climb Channel Solutions
Via GlobeNewswire
Tickers CLMB
News headline image
Garrett Motion to Hold Third Quarter 2026 Financial Results Conference Call on Thursday October 29th, 2026
From Garrett Motion Inc.
Via GlobeNewswire
Tickers GTX
News headline image
Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film
From Eton Pharmaceuticals; Aquestive Therapeutics, Inc.
Via GlobeNewswire
Tickers AQST ETON
News headline image
SOPRIS TECHNOLOGIES Appoints Global Technology Executive Hari Haran to Board of Directors
From Sopris Technologies, Inc.
Via GlobeNewswire
News headline image
National Fuel Gas Company Announces Plan to Separate Its Integrated Upstream and Gathering Business
From National Fuel Gas Company
Via GlobeNewswire
Tickers NFG
News headline image
Ocugen and Roots Pharmaceutical Complete License Agreement for OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa
From Ocugen
Via GlobeNewswire
Tickers OCGN
News headline image
Robbins Geller Rudman & Dowd LLP, Girard Sharp LLP, and The Hall Firm, Ltd. Attorneys File Securities Class Action Against Compass, Inc. (NYSE: COMP)
From Girard Sharp LLP
Via GlobeNewswire
Tickers COMP
News headline image
GoCharting Receives Dhan's Tech Innovators Award and Is Named One of Dhan's Top Partners of 2026
From GoCharting
Via GlobeNewswire
News headline image
onsemi and Sungrow Advance Utility-Scale Energy Storage Performance with SiC Hybrid Technology
From onsemi
Via GlobeNewswire
Tickers ON
News headline image
Owlting Group (NASDAQ: OWLS) and Decaf Open U.S. Dollar Accounts Beyond the United States on OwlPay Harbor
From OwlTing Group
Via GlobeNewswire
Tickers OWLS
News headline image
Sonatype Unveils Nexus Repository Pro+ to Stop Malicious Components Before Developers or AI Agents Pull Them Into Builds
From Sonatype
Via GlobeNewswire
News headline image
Dryden Gold Corp. Presenting at the OTC Precious Metals & Critical Minerals Virtual Investor Conference
From Virtual Investor Conferences
Via GlobeNewswire
Tickers DRYGF TSX-V:DRY.V
News headline image
KBR Dividend Declaration
From Kellogg Brown & Root LLC.
Via GlobeNewswire
Tickers KBR
News headline image
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Lennar Corporation Investors Who Received Millrose Properties, Inc. (MRP) Shares in February 2025 Spin-Off to Contact the Firm
From Girard Sharp LLP
Via GlobeNewswire
Tickers MRP
News headline image
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Liberty Broadband Corporation Investors Who Received Charter Communications, Inc. (NASDAQ: CHTR) Shares in Connection with Charter Communications’ Acquisition of Liberty Broadband in August
From Girard Sharp LLP
Via GlobeNewswire
Tickers CHTR
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.